Skip to content

Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease

ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Patients Undergoing Percutaneous Coronary Intervention

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00905294
Acronym
ADVANCE-PCI
Enrollment
11
Registered
2009-05-20
Start date
2009-08-31
Completion date
2010-08-31
Last updated
2013-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The purpose of this research is to determine the relationship between proteins and enzymes in the blood and how they work with platelets to form blood clots in patients with coronary artery disease. The investigators hypothesize that the relationship between these factors could potentially be useful in identifying patients at higher risk for heart attacks.

Interventions

OTHERBlood draws

Observational: blood draws only

Sponsors

Royal College of Surgeons, Ireland
CollaboratorOTHER
University College Cork
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission to hospital with suspected index event of Non-ST-Elevation Myocardial Infarction (NSTEMI), Unstable Angina (UA) or Stable Angina (SA) * Planned percutaneous coronary intervention during admission

Exclusion criteria

* Recent history (\< 6 months) of an acute coronary syndrome (other than current admission) or stroke * Recent history (\< 6 months) of major surgery, trauma or thromboembolic event * Percutaneous coronary or peripheral intervention or any stent placement performed within the past 6 months * Current evidence of infection

Design outcomes

Primary

MeasureTime frameDescription
relationships between ADAMTS-13 activity, von Willebrand factor antigen and platelet-monocyte aggregates levelschange from baseline to after percutaneous coronary interventionAssess the relationships between ADAMTS-13 activity, von Willebrand factor antigen and platelet-monocyte aggregates levels in subjects with coronary artery disease prior to and after undergoing PCI in this exploratory study

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026